Riskpilot← Back to searchSign inGet full accessLSH-BIOTECH ApS
APSBankruptCVR 30827538Emilsvej 32Activities of agents involved in the wholesale of other particular products · NACE 4618Est. 20071 employees
Revenue 2020
DKK 1,2M
+64% vs 2019
EBITDA margin
73.9%
+111% vs 2019
Equity ratio
54.7%
Financial strength
Net profit 2020
DKK 674K
+129% vs 2019
| Revenue | DKK 1,2M | +64% |
| EBITDA | DKK 871K | +111% |
| Net profit | DKK 674K | +129% |
| Total assets | DKK 1,6M | +291% |
| Equity | DKK 863K | +355% |
| Employees | 1 | — |
Legal name
LSH-BIOTECH ApS
CVR number
30827538
Legal form
Anpartsselskab
NACE code
4618 · Activities of agents involved in the wholesale of other particular products
Founded
17. september 2007
Share capital
DKK 125.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2020-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør eller af den samlede bestyrelse.
Address
Emilsvej 32
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 297 | 469 | 698 | 979 | 1.528 | 954 | 850 | 721 | 1.179 |
| Staff expenses | -352 | -330 | -369 | -357 | -339 | -332 | -378 | -309 | -308 |
| EBITDA | -55 | 139 | 328 | 622 | 1.190 | 622 | 471 | 412 | 871 |
| Depreciation & amort. | -17 | -17 | -17 | -14 | -70 | -70 | -40 | -9 | -0 |
| EBIT | -72 | 121 | 311 | 609 | 1.120 | 552 | 431 | 404 | 871 |
| Net financials | -1 | -1 | -3 | -2 | -7 | -9 | -9 | -22 | -6 |
| Profit before tax | -73 | 120 | 308 | 607 | 1.113 | 544 | 422 | 382 | 865 |
| Tax | 7 | 15 | 79 | 147 | 252 | 135 | 80 | 88 | 191 |
| Net profit | -80 | 105 | 228 | 460 | 861 | 409 | 343 | 294 | 674 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 566 | 517 | 840 | 1.575 | 2.176 | 1.323 | 1.598 | 403 | 1.577 |
| Equity | 231 | 336 | 564 | 1.024 | 1.385 | 794 | 737 | 190 | 863 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 74 | 191 |
| Short-term debt | 334 | 180 | 276 | 547 | 791 | 529 | 862 | 139 | 523 |
| Total debt | 334 | 180 | 276 | 547 | 791 | 529 | 862 | 214 | 714 |
EBITDA margin
73.9%
This company
15.8%
Market median
+368% vs market
20122020
Equity ratio
54.7%
This company
38.2%
Market median
+43% vs market
20122020
Return on equity
78.0%
This company
18.4%
Market median
+324% vs market
20122020
Net profit margin
57.1%
This company
8.1%
Market median
+605% vs market
20122020
Asset turnover
0.75×
This company
1.12×
Market median
-33% vs market
20122020
Debt / equity
0.83×
This company
0.62×
Market median
+34% vs market
20122020
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via CVR / Virk · Period 2015-10-01 – 2016-09-30
- Annual report 2015Filed via CVR / Virk · Period 2014-10-01 – 2015-09-30
- Annual report 2014Filed via CVR / Virk · Period 2013-10-01 – 2014-09-30
- Annual report 2013Filed via CVR / Virk · Period 2012-10-01 – 2013-09-30
- Annual report 2012Filed via CVR / Virk · Period 2011-10-01 – 2012-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
GT | Audit | 2007 | — | — |
ND Management | Management | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — | |
| Chairman | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
LSH GRENAA HOLDING ApS | Company | 100.0% | 100.0% | 2007 |
Biovision Holding ApS | Company | 100.0% | 100.0% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LSH-BIOTECH ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gunnar Thybo Johansen | Audit | 0 companies |
| Niels-Christian Dreyer | Management | 0 companies |
| Ellen Marie Vestergaard | Board of Directors | 0 companies |
| Leif Skødt Hansen | Chairman | 0 companies |